Jason C Gallagher

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)

Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker et al. · Clinical Infectious Diseases · 2022 · 201 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Madeline King, Emily L. Heil, Safia Kuriakose et al. · Antimicrobial Agents and Chemotherapy · 2017 · 132 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study

Jason C Gallagher, Michael J. Satlin, Abdulrahman Elabor et al. · Open Forum Infectious Diseases · 2018 · 130 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant <i>Acinetobacter baumannii</i> Among Patients From Different Global Regions

Minggui Wang, Lizhao Ge, Liang Chen et al. · Clinical Infectious Diseases · 2023 · 94 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials

Julie Ann Justo, Timothy P. Gauthier, Marc H. Scheetz et al. · Clinical Infectious Diseases · 2014 · 85 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacy Practice +13